Showing 4,281 - 4,300 results of 4,368 for search '(( significant decrease decrease ) OR ( significant clinical decrease ))~', query time: 0.32s Refine Results
  1. 4281

    Data Sheet 1_Therapeutic potential of Glycyrrhiza polysaccharides in pseudorabies virus infection: immune modulation, antioxidant activity, and gut microbiota restoration.pdf by Chunlian Song (4635886)

    Published 2025
    “…</p>Results<p>GP administration significantly alleviated PRV-induced symptoms, reduced mortality and disease activity index, and improved food intake. …”
  2. 4282

    DataSheet1_Identification of telomere-related lncRNAs and immunological analysis in ovarian cancer.docx by Weina Xu (558990)

    Published 2024
    “…</p>Methods<p>Relevant mRNA and clinical data for OC were sourced from The Cancer Genome Atlas (TCGA) database. …”
  3. 4283

    Data Sheet 1_Influence of age-adjusted shock index trajectories on 30-day mortality for critical patients with septic shock.zip by Suru Yue (12194255)

    Published 2025
    “…KM curve revealed significantly higher 30-day mortality in Class 2 (32.1%) and Class 3 (38.7%) than Class 1 (12.3%) (P < 0.001). …”
  4. 4284

    Data Sheet 1_Comprehensive metagenomic and lipidomic analysis showed that baicalin could improve depressive behaviour in atherosclerotic mice by inhibiting nerve cell ferroptosis.z... by Peng Ren (337555)

    Published 2025
    “…Metabolic pathway enrichment analysis showed that differential lipid PEs were significantly enriched in the iron death pathway, and our further in vitro cellular experiments showed that baicalin could inhibit Erastin-induced Ferroptosis in the hippocampal neuronal cell line HT-22 by promoting the expression of SLC7A11, GSH, and GPX4, inhibiting the expression of ACSL4, and decreasing the cellular ROS.…”
  5. 4285

    Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial by Trupti Nagendra Prasad (17266455)

    Published 2025
    “…</p><p dir="ltr">Design: 72-week, randomized, open-label, blinded-endpoint (PROBE) pilot clinical trial (CTRI/2022/02/039978).</p><p dir="ltr">Setting: Single tertiary care center in India.…”
  6. 4286

    Figure 6 from Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes by Laura Kuett (20493991)

    Published 2025
    “…Circles display significantly enriched (red) or decreased (blue; FDR < 0.05; multiple testing correction with the Benjamin–Hochberg method) results, with size indicating the log-transformed fold change.  …”
  7. 4287

    Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization by Yu-Xuan Yao (21338594)

    Published 2025
    “…</p> <p>After meta-analyses of both discovery and validation cohorts, genetically proxied GLP1R agonist was found to significantly associated with a decreased risk of diabetic nephropathy (OR = 0.72, 95%CI = 0.54–0.97, <i>p</i> = 0.031) and IgA nephropathy (OR = 0.58, 95%CI = 0.36–0.94, <i>p</i> = 0.027). …”
  8. 4288

    Table 1_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.docx by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  9. 4289

    Image 3_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.jpg by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  10. 4290

    Image 1_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.jpg by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  11. 4291

    Image 4_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.jpg by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  12. 4292

    Data Sheet 2_The effect of training intervention based on health belief model on self-care behaviors of women with gestational diabetes mellitus.pdf by Fatemeh Mohammadkhah (14157844)

    Published 2025
    “…Also, the comparison of averages of blood sugar levels after the intervention in the two groups indicated that fasting blood sugar level, A1C hemoglobin, and blood sugar levels measured 2 h after the meal significantly decreased in the intervention group (p < 0.001). …”
  13. 4293

    Table 2_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.docx by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  14. 4294

    Data Sheet 6_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.pdf by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  15. 4295

    Data Sheet 1_The effect of training intervention based on health belief model on self-care behaviors of women with gestational diabetes mellitus.pdf by Fatemeh Mohammadkhah (14157844)

    Published 2025
    “…Also, the comparison of averages of blood sugar levels after the intervention in the two groups indicated that fasting blood sugar level, A1C hemoglobin, and blood sugar levels measured 2 h after the meal significantly decreased in the intervention group (p < 0.001). …”
  16. 4296

    Data Sheet 4_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.pdf by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  17. 4297

    Data Sheet 3_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.pdf by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  18. 4298

    Data Sheet 5_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.pdf by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  19. 4299

    Image 2_A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.jpg by Paolo Romania (399007)

    Published 2025
    “…This finding holds promise for improving the efficacy of NK cell-based immunotherapies and advancing their clinical application.</p>…”
  20. 4300

    Impact of moderate-to-severe ulcerative colitis and Crohn’s disease on sexual activity: United States and European patient perspectives from the communicating needs and features of... by Marla C. Dubinsky (10978320)

    Published 2025
    “…Of these, most US (UC: 63%, CD: 69%) and European (UC: 53%, CD: 56%) patients reported avoiding or decreasing sexual activity due to UC or CD in the past 3 months; however, the proportion was significantly greater among US patients (<i>p</i> <.05). …”